Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study of AG-80308 in Dry Eye Patients
- First Posted Date
- 2022-05-12
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Allgenesis Biotherapeutics Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT05372107
- Locations
- 🇺🇸
Eye Research Foundation, Newport Beach, California, United States
🇺🇸Andover Eye Associates, Raynham, Massachusetts, United States
🇺🇸Alpine Research Organization, Inc., Clinton, Utah, United States
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2025-10-15
- Lead Sponsor
- Allgenesis Biotherapeutics Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT05301751
- Locations
- 🇺🇸
Retina Vitreous Associates of Florida, St. Petersburg, Florida, United States
🇺🇸Center of Macula and Retina Disease, Winter Haven, Florida, United States
🇺🇸Retina Research Institute of Texas, Abilene, Texas, United States
A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia
- Conditions
- Pterygium
- Interventions
- Drug: 0.1% AG-86893 Eye DropsDrug: Vehicle Eye DropsDrug: 0.3% AG-86893 Eye Drops
- First Posted Date
- 2018-05-23
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Allgenesis Biotherapeutics Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT03533244
- Locations
- 🇦🇺
M.T. Coroneo Pty Ltd, Randwick, New South Wales, Australia
🇦🇺H2Vision Centre, Sippy Downs, Queensland, Australia
🇦🇺Bendigo Eye Clinic, Bendigo, Victoria, Australia